Health Care [ 8/12 ] | Pharmaceuticals [ 50/74 ]
NYSE | Common Stock
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health.
The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally.
The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018.
Bausch Health Companies Inc. is headquartered in Laval, Canada.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 29, 26 | 0.78 Increased by +27.87% | 0.69 Increased by +13.04% |
| Feb 25, 26 | 1.10 Decreased by -5.09% | 1.21 Decreased by -9.02% |
| Oct 29, 25 | 1.16 Increased by +2.65% | 1.06 Increased by +9.43% |
| Jul 30, 25 | 0.40 Decreased by -59.18% | 0.05 Increased by +700.00% |
| Apr 30, 25 | 0.61 Increased by +3.39% | 0.85 Decreased by -28.24% |
| Feb 20, 25 | 1.16 Increased by +0.87% | 1.13 Increased by +2.96% |
| Oct 30, 24 | 1.13 Increased by +9.71% | 1.02 Increased by +10.78% |
| Aug 1, 24 | 0.98 Increased by +20.99% | 0.88 Increased by +11.36% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 2.49 B Increased by +10.52% | -1.40 B Decreased by -2.33 K% | Decreased by -56.38% Decreased by -2.10 K% |
| Dec 31, 25 | 2.84 B Increased by +10.94% | -113.72 M Decreased by -222.28% | Decreased by -4.01% Decreased by -210.22% |
| Sep 30, 25 | 2.65 B Increased by +5.61% | 176.99 M Increased by +308.22% | Increased by +6.68% Increased by +297.16% |
| Jun 30, 25 | 2.57 B Increased by +7.09% | 150.53 M Increased by +1.41 K% | Increased by +5.85% Increased by +1.31 K% |
| Mar 31, 25 | 2.25 B Increased by +4.61% | -57.82 M Increased by +9.24% | Decreased by -2.57% Increased by +13.24% |
| Dec 31, 24 | 2.56 B Increased by +6.27% | 93.00 M Increased by +338.46% | Increased by +3.63% Increased by +324.39% |
| Sep 30, 24 | 2.51 B Increased by +12.15% | -85.00 M Increased by +77.51% | Decreased by -3.39% Increased by +79.95% |
| Jun 30, 24 | 2.40 B Increased by +10.89% | 10.00 M Decreased by -61.54% | Increased by +0.42% Decreased by -65.32% |